Kanglaite enhances the efficacy of cisplatin in suppression of hepatocellular carcinoma via inhibiting CKLF1 mediated NF-κB pathway and regulating transporter mediated drug efflux
Bibliographic Data
| ID | 14744160 |
|---|---|
| Authors | Chen Chen (0000-0002-9786-8003, Lanzhou University), Qidi Ai (0000-0002-1647-2825, Hunan University of Traditional Chinese Medicine), Qi-Di Ai, Yu-hui Wei, Yuhui Wei (0000-0002-5165-7737, First Hospital of Lanzhou University, corresponding author) |
| Year | 2021 |
| Volume | 264 |
| Pages | 113388 |
| Publication date | 2021-01-01 |
| Open Access | Yes |
| Type | ARTICLE |
| Venue | Journal of Ethnopharmacology (JOURNAL) |
| Journal identifiers | ISSN: 0378-8741 • E-ISSN: 1872-7573 |
| Publisher | Elsevier BV (PUBLISHER) |
| DOI | 10.1016/j.jep.2020.113388 |
| PMID | 32918990 |
| OpenAlex | W3084016656 |
| Language | EN |
| Citations received | 3 |
| References cited | 68 |
ATP-binding cassette transporter · Biology · Cell · Chemotherapy · Cisplatin · Efflux · Hepatocellular carcinoma · Multidrug resistance-associated protein 2 · Transporter · Viability assay · Western blot · Chemistry · Ginger and Zingiberaceae research · Medicine · Microbial Metabolism and Applications · Neurological Disease Mechanisms and Treatments · Biochemistry · Cancer Research · Internal Medicine · Molecular Biology · Pharmacology
Mechanism of Shashen-Maidong herb pair in treating hepatocellular carcinoma using network pharmacology and experimental validation
CYP3A4 and MRP2 are predominant metabolic regulators attribute to the toxicity/efficacy of aconitine derived from Fuzi
Research on Coix seed as a food and medicinal resource, it's chemical components and their pharmacological activities
Global cancer statistics, 2012
Inflammation and metabolic disorders
Global surveillance of trends in cancer survival 2000–14 (Concord-3)
Antitumor activity and immunomodulatory effects of the intraperitoneal administration of Kanglaite in vivo in Lewis lung carcinoma
Inhibition of Coix seed extract on fatty acid synthase, a novel target for anticancer activity
| Citations per year | 1.5 |
|---|---|
| Citation span | 2024 - 2025 (2) |
| Highly cited | No |